产品说明书

Busulfan

Print
Chemical Structure| 55-98-1 同义名 : 1,4-双甲基硫氧基丁烷 ;Busulphan;NSC-750;14di(methylsulfonyloxy)butane.;14di(methanesulfonyloxy)butane;14butanediol dimethylsulfonate;14bitanediol dimethanesulfonate esters;14bis(methanesulfonoxy)butane;Chemical structure names: ;WR19508;GT41;Code names: CB2041;BUS;Abbreviations: BU;Misulfan;Misulban;Sulfabutin;Myelosan;Myeleukon;methanesulfonic acid tetramethylene ester;glyzophrol;Busulfanum;Bussulfam;NCI C01592;Myleran;Mylecytan;Myeloleukon;Milecitan;Mielosan
CAS号 : 55-98-1
货号 : A593389
分子式 : C6H14O6S2
纯度 : 98%
分子量 : 246.302
MDL号 : MFCD00007562
存储条件:

粉末 Inert atmosphere,Room Temperature

液体 -20°C:3-6个月-80°C:12个月

溶解度 :

DMSO: 50 mg/mL(203 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

动物实验配方:

IP 2% DMSO+2% Tween80+40% PEG300+water 10 mg/mL clear

PO 0.5% CMC-Na 44 mg/mL suspension

生物活性
描述 Busulfan (BU), an alkylating agent that causes DNA damage by cross-linking DNAs and DNA and proteins, induces senescence in normal human diploid WI38 fibroblasts through the extracellular signal-regulated kinase (Erk) and p38 mitogen-activated protein kinase (p38 MAPK) cascade independent of the p53-DNA damage pathway[3]. Busulfan (40 mg/kg, i.p) increases apoptosis and decreases the testis weight in mice. The testes of Busulfan-treated mice exhibits higher level of pRB expression, inhibits Rb phosphorylation and PCNA expression compared to the control[4]. Busulfan (2.5, 5.0 mg/kg, i.p.) causes earlier occurrence of persistent esturs in a dose dependent manner in rats. Busulfan (5.0 mg/kg) also increases the incidence of uterine adenocarcinomas and multiplicity of uterine neoplastic lesions. In addition, Busulfan decreases the serum 17β-estradiol(E2), progesterone and inhibin levels in rats, and elevates the E2/progesterone ratio only at 5.0 mg/kg[5]. IV busulfan is a convenient, safe, and effective conditioning agent used in HSCT (hematopoietic stem cell transplantation) that has a predictable pharmacokinetic profile[6].
细胞研究
细胞系 浓度 检测类型 检测时间 活动说明 数据源
Kelly cells 10-100 μM Proliferation assay 72 h Antiproliferative activity against human Kelly cells at 10 to 100 uM after 72 hrs by MTT assay 24814532
LS cells 10-100 μM Proliferation assay 72 h Antiproliferative activity against human LS cells at 10 to 100 uM after 72 hrs by MTT assay 24814532
SiMa cells 10-100 μM Proliferation assay 72 h Antiproliferative activity against human SiMa cells at 10 to 100 uM after 72 hrs by MTT assay 24814532
临床研究
NCT号 适应症或疾病 临床期 招募状态 预计完成时间 地点
NCT02114502 Myeloma Phase 2 Withdrawn - -
NCT00997386 Hematologic Neoplasms ... 展开 >> Multiple Myeloma Anemia, Aplastic Hemoglobinuria, Paroxysmal Myelofibrosis 收起 << Phase 2 Completed - United States, Arizona ... 展开 >> University Medical Center and UMC-North Clinic Tucson, Arizona, United States, 85719 收起 <<
NCT01471444 Disorder Related to Bone Marro... 展开 >>w Transplantation Leukemia Transplantation Infection 收起 << Phase 3 Active, not recruiting November 1, 2020 United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 <<
实验方案
1mg 5mg 10mg

1 mM

5 mM

10 mM

4.06mL

0.81mL

0.41mL

20.30mL

4.06mL

2.03mL

40.60mL

8.12mL

4.06mL

参考文献

[1]Probin V, Wang Y, et al. Busulfan-induced senescence is dependent on ROS production upstream of the MAPK pathway. Free Radic Biol Med. 2007 Jun 15;42(12):1858-65. Epub 2007 Mar 31.

[2]Meng A, Wang Y, et al. Ionizing radiation and busulfan induce premature senescence in murine bone marrow hematopoietic cells. Cancer Res. 2003 Sep 1;63(17):5414-9.

[3]Probin V, Wang Y, Zhou D. Busulfan-induced senescence is dependent on ROS production upstream of the MAPK pathway. Free Radic Biol Med. 2007 Jun 15;42(12):1858-65

[4]Choi YJ, Ok DW, Kwon DN, Chung JI, Kim HC, Yeo SM, Kim T, Seo HG, Kim JH. Murine male germ cell apoptosis induced by busulfan treatment correlates with loss of c-kit-expression in a Fas/FasL- and p53-independent manner. FEBS Lett. 2004 Sep 24;575(1-3):41-51

[5]Yoshida M, Watanabe G, Shirota M, Maekawa A, Taya K. Reduction of primordial follicles caused by maternal treatment with busulfan promotes endometrial adenocarcinoma development in donryu rats. J Reprod Dev. 2005 Dec;51(6):707-14

[6]Fisher VL, Barnes YJ, Nuss SL. Pretransplant conditioning in adults and children: dose assurance with intravenous busulfan. Oncol Nurs Forum. 2006 Nov 3;33(2):E36-43

[7]Chen YF, Zhao ZQ, Wu ZM, et al. The role of RIP1 and RIP3 in the development of aplastic anemia induced by cyclophosphamide and busulphan in mice. Int J Clin Exp Pathol. 2014;7(12):8411-8420.